This group includes preparations for local and systemic use, and also some preparations used for dissolving clots in catheters, hemodialysis clots etc. See also: V07A - All other non-therapeutic products B01AB - Heparin group
B06AC - Drugs Used in Hereditary Angioedema
The DDD for lanadelumab is based on the starting dose.